District of Columbia Department of Health Patricia M. D’Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control Health Regulation and Licensing Administration Board of Pharmacy and Pharmaceutical Control
District of Columbia Department of Health. Health Regulation and Licensing Administration Board of Pharmacy and Pharmaceutical Control. Patricia M. D’Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control September 28, 2013. Organization. - PowerPoint PPT Presentation
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
District of ColumbiaDepartment of Health
Patricia M. D’Antonio, RPh, MS, MBA,CGPExecutive Director, Board of Pharmacy
Program Manager, Pharmaceutical ControlSeptember 28, 2013
Health Regulation and Licensing AdministrationBoard of Pharmacy and Pharmaceutical Control
Organization
• Health Professions Licensing Administration – Board of Pharmacy
Board of Pharmacy• The mission of Board of Pharmacy is to protect
and improve the public health through the efficient and effective regulation of the practice of Pharmacy and Pharmaceutical Detailing; through the licensure of Pharmacist, Pharmaceutical Detailers and Pharmacy Interns.
Liaison RoleBetween District and Federal entities:• Food and Drug (FDA)• Drug Enforcement Administration (DEA)• Health Human Service (HHS)• Consumer Protection Agency• And others involving regulatory
control matters related to medications
Pharmacy Law and Regulations
• DC Code Title 47, Section 2885.01 Pharmacy
• DC Code Title 48, Section 701-901Pharmacy related laws
• Federal Law– Code of Federal Regulations (CFR) 21, Part 1
• Section 1300 - Drugs
Pharmacy Law and Regulations• DCMR Title 22 Public Health & Medicine
Chapter 4 – Distribution, Manufacturer, or Wholesaler of Drugs
Chapter 5 – Safe Disposal of MedicationsChapter 10 – Controlled Substance Registration for
Manufacturers, Distributors, and DispensersChapter 12 – Controlled SubstancesChapter 13 – Prescription and DistributionChapter 15 – InspectionsChapter 19 – Pharmacies
Laws/Regulations
• DCMR Title 17 Business, Industry Professions– Chapter 40 – Health Occupations, General
• Criminal Background Check• Immunization Updates • Safe Disposal of Unused Pharmaceuticals• Collaborative Practice• Pharmacy Technician • Prescription Drug Monitoring Program
Criminal Background Check
• As of January 3, 2011• Initial, renewal or reinstatement license• All health care professionals• FBI and Local • Repeat every 4 years• Through Morpho Trust Services• In District/Out of District Process• http://doh.dc.gov/cbc
• 17 DCMR Section 6512• Effective, June 8, 2012• immunize patients twelve (12) years and
older with parental consent or patients eighteen (18) years and older that present valid identification for specific vaccinations by protocol
Immunization• Obtain written protocol for the vaccinations from
a physician • Report vaccine administration to the physician
listed on the Vaccination Protocol and to the patient’s primary care physician.
• Adverse events reporting requirements– Pharmaceutical Control Division– Director of the Department of Health – within 48 hours of the discovery of occurrence
but not limited to H1N1 and other epidemic vaccinations specified by the World Health Organization or the Center for Disease Control at the time of vaccination
Immunization
• Registration with the Board required – not new but seems to cause confusion– FAQs on Board of Pharmacy website– Pharmacist License not Facility License
Safe Disposal of Unused Pharmaceuticals
• Unused Pharmaceutical Safe Disposal Act of 2009 (legislation)
• Applies to Health Care Facilities
• Facilities shall not disposed of unused pharmaceuticals by flushing the product down a drain or any method that uses the public sewer system
Safe Disposal of Unused Pharmaceuticals
• Subject to a civil fine of up to one thousand dollars ($1,000) per occurrence; and
• Required to submit to the Board of Pharmacy, or its designee, a mitigation plan designed to prevent further such occurrences within thirty (30) days of receipt of a request for the mitigation plan
Collaborative Practice
• Collaborative Care Expansion Amendment Act of 2012 passed in May 31, 2013
• Regulations pending from Board of Pharmacy and Board of Medicine
• Voluntary written agreement• Between a licensed pharmacist and a
licensed physician or another health practitioner with independent prescriptive authority
Collaborative Practice
• Defines the scope of practice between the licensed pharmacist and licensed physician, or other health practitioner, – Licensed by a District health occupation board
• Initiation, modification, or discontinuation of a drug therapy regimen
Collaborative Practice Agreements• Specification of the drug therapy to be provided
and any tests that may be necessarily incident to its provision;
• Conditions for initiating, modifying, or discontinuing a drug therapy; and
• Directions concerning the monitoring of a drug therapy and the conditions that would warrant a modification
• Establish policies and procedures for approving, disapproving, and revoking collaborative practice agreements.
Pharmacy Technician
• Pharmacy Technician Amendment Act– Passed July 19, 2013
• 17 years of age• A high school diploma or its equivalent, or
has passed a Board-approved examination that proves that he or she has achieved competency in the educational skills required to perform the function of a pharmacy technician; and
Pharmacy Technician• A current certification from the Pharmacy
Technician Certification Board, the National Health Career Association, or another national or state certifying organization approved by the Board; or
• Successfully completed one of the following types of pharmacy training programs, which shall include a Board-approved exam:
Technician Training Programs• (i) A national, regional, or state accredited pharmacy technician
training program recognized by the Board;• (ii) A pharmacy technician program at a college or university that is
accredited by an accrediting body recognized by the Secretary of the United States Department of Education or the Council on Postsecondary Accreditation
• (iii) An employer-based pharmacy technician training program recognized by the Board that includes within a one-year period a minimum of 160 hours of training, including theoretical and practical instruction; or
• (iv) A pharmacy technician program that meets the guidelines of the American Society of Health-System Pharmacists, is licensed by the District of Columbia Educational Licensure Commission, and has certified to the Board its intent to pursue accreditation upon becoming eligible to do so.
Pharmacy Technician
• Grandfather Clause• Defines the roles of ancillary personnel• Addresses supervision responsibilities of a
pharmacist• Regulations pending Board of Pharmacy
– Legislation provides one year– Monitor communications and DC Register for
Proposed Regulations
Prescription Drug Monitoring Program
• Tool for practitioners to review prior to writing controlled substance prescription
• Legislation introduced in 2012
• Hearing held in July 2013
• Expected passage by end of 2013
Findings on Inspection• Failure to document administration and/or
wasting of CSII substances• Failure to obtain drugs from an approved
supplier• Failure to conduct CSII audit as indicated• Medication Administration Records (MARs) not
consistently reflecting current date and time• Physician signature log missing DC Controlled
Substance and DEA numbers and respective expiration dates
Compounding
• preparation, mixing, assembling, packaging, or labeling of a drug or device
• result of a practitioner’s prescription drug order or for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing
• in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns
Manufacturing
• prepare, produce, propagate, compound, convert, process, or package a drug, either directly or indirectly, by extraction from a substance of natural origin, or independently by means of chemical synthesis
Manufacturing
• any packaging or repackaging of the substance or drug; labeling or relabeling of any drug package or container to further distribution from the original place of manufacture to the person who makes final delivery, distribution, or sale to the ultimate consumer or user
AccessRxPrescription Drug Marketing
Costs• manufacturers and labelers of prescription
drugs who engage in marketing in District report their costs for pharmaceutical drug marketing in the District